Alameda, CA, United States of America

Daniel Byun

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Discovering Daniel Byun: The Innovative Mind from Alameda

Introduction:

Daniel Byun, a remarkable inventor hailing from Alameda, CA, has made significant strides in the field with his remarkable contributions to the pharmaceutical industry. With a portfolio boasting of 10 patents, Daniel Byun's legacy is truly one of innovation and excellence.

Latest Patents:

Daniel Byun's recent patents include groundbreaking inventions such as "Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity." These patents highlight his expertise in developing pharmaceutical compositions that have the potential to revolutionize the field.

Career Highlights:

Having worked with prestigious companies such as Theravance Respiratory Company, LLC and Theravance, Inc., Daniel Byun has honed his craft and gained invaluable experience in the industry. His tenacity and dedication have allowed him to excel in his career and make a lasting impact in the world of innovation.

Collaborations:

Throughout his career, Daniel Byun has collaborated with esteemed professionals such as Adam D Hughes and John R Jacobsen. These collaborations have not only enriched his work but have also led to the development of groundbreaking inventions that have the potential to change lives.

Conclusion:

In conclusion, Daniel Byun's journey as an inventor is a testament to his passion for innovation and his commitment to pushing the boundaries of what is possible in the pharmaceutical industry. His impressive portfolio of patents and successful collaborations underscore his status as a visionary in the field, with many eagerly anticipating his future contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…